A New-Onset Facial Lesion in a Hospitalized COVID-19 Patient

Emelie E Nelson1, Morgan A Rousseau1, Cassandra A Mohr1

  • 1Dermatology, John P. and Kathrine G. McGovern Medical School at UTHealth, Houston, USA.

Cureus
|June 5, 2023
PubMed

Insights

This case report details a rare facial pressure ulcer in a COVID-19 patient despite regular bed rotation. It highlights the need for awareness of atypical pressure ulcer locations during specialized treatments.

Area of Science:

  • Medicine
  • Wound Care
  • Critical Care

Background:

  • Pressure ulcers commonly develop in bedridden patients due to prolonged skin compression, particularly over bony prominences.
  • Preventative measures, such as regular repositioning, are crucial in mitigating the risk of pressure ulcer development.
  • Hospitalized patients, especially those with limited mobility, are at a significant risk for these complications.

Observation:

  • A rare case of a facial pressure ulcer is presented in a patient with COVID-19.
  • The ulcer developed despite the implementation of regular rotational bed treatment.
  • This atypical presentation occurred in the context of prone-positioning therapy, commonly used for COVID-19 patients.

Findings:

  • The facial pressure ulcer, though unusual, was successfully managed with dedicated wound care protocols.
  • The lesion healed effectively through secondary intention, indicating a positive response to treatment.
  • This case underscores the possibility of pressure ulcer formation even with standard preventative measures in place.

Implications:

  • Increased clinical awareness is needed regarding the potential for atypical pressure ulcer locations, such as the face.
  • The findings are particularly relevant given the increasing use of prone-positioning in managing severe respiratory illnesses like COVID-19.
  • This case highlights the importance of vigilant skin assessment and tailored preventative strategies in high-risk patient populations.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
14
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
287
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
402
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
235
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
291
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
254